Abstract Number: 2505 • 2013 ACR/ARHP Annual Meeting
Higher Disease Damage Among African Americans With Familial Versus Sporadic Systemic Lupus Erythematosus
Background/Purpose: Studies in predominantly Caucasian cohorts have found no significant clinical or serologic differences in systemic lupus erythematosus (SLE) patients with a family history of…Abstract Number: 2506 • 2013 ACR/ARHP Annual Meeting
Systemic LUPUS Erythematosus Patients Presenting With Immune Thrombocytopenia and The Association Between Two Diseases
Background/Purpose: We evaluated the features of our systemic lupus erythematosus (SLE) patients who presented with immune thrombocytopenia (ITP) and compared them to other SLE patients.…Abstract Number: 2507 • 2013 ACR/ARHP Annual Meeting
What Is The Risk Of Having a Total Hip Or Knee Replacement for Patients With Lupus?
Background/Purpose: Individuals with systemic lupus erythematosus (SLE) frequently have arthralgia, but joint damage leading to surgery is thought to be less common. In addition to…Abstract Number: 2508 • 2013 ACR/ARHP Annual Meeting
Clinical and Serological Discordance In The Systemic Lupus Erythematosus International Collaborating Clinics (SLICC) Cohort
Background/Purpose: Anti-DNA antibodies and serum complement levels are considered important biomarkers for disease activity in SLE. Despite this many SLE patients present serologically active (positive…Abstract Number: 2509 • 2013 ACR/ARHP Annual Meeting
Long Term Natural History Of Asymptomatic Avascular Necrosis In a Cohort Of Patients With Systemic Lupus Erythematosus Treated With Corticosteroids
Background/Purpose: Avascular necrosis (AVN) is cellular death of bone components due to interruption of the blood supply resulting in area of ischemic necrosis but may…Abstract Number: 2510 • 2013 ACR/ARHP Annual Meeting
The Epidemiology Of Systemic LUPUS Erythematosus and Clinical Features Of Patients At A Single Center In Northwestern Turkey
Background/Purpose: We evaluated the clinical features, treatment modalities, treatment responses and prognosis of patients diagnosed with systemic lupus erythematosus (SLE). We also estimated the prevalence…Abstract Number: 2511 • 2013 ACR/ARHP Annual Meeting
Multicenter Validation Of The Lupus Activity Scoring Tool (LAST) As Compared To The Selena Sledai (SS) Modification
Background/Purpose: Systemic Lupus Erythematosus (SLE) is a chronic immune modulated disease with variable clinical manifestations. New advances in the management of SLE mandated closer monitoring…Abstract Number: 2473 • 2013 ACR/ARHP Annual Meeting
Comparison Of The Two Subtypes Of Axial Spondyloarthritis Patients Fulfilling The Imaging Arm Based On Radiographic and MRI Findings
Background/Purpose: New Axial Spondyloarthritis Classification Criteria include an imaging arm and a clinical arm. The imaging arm includes radiographic ax-SpA patients who have radiographic sacroilitis…Abstract Number: 2478 • 2013 ACR/ARHP Annual Meeting
Clinical Characteristics Of Patients With Early Spondyloarthritis. Results From a Specialized Consultation In a Clinical Hospital
Background/Purpose: The classification criteria for spondyloarthritis (SpA) intend to identify patients with this disease from the initial stages. The nonspecific characteristics, symptoms, signs, and additional…Abstract Number: 2471 • 2013 ACR/ARHP Annual Meeting
Prevalence Of Inflammatory Back Pain In Psoriatic Arthritis: The Prepare Study
Background/Purpose: Up to 30% of patients with psoriasis (Ps) may develop psoriatic arthritis (PsA); ranging from mild and non-destructive disease to severe and erosive arthritis.1…Abstract Number: 2472 • 2013 ACR/ARHP Annual Meeting
Disease Burden Is Similar Between Non-Radiographic Axial Spondyloarthritis and Ankylosing Spondylitis and Independent Of Gender Influences
Disease Burden is Similar between Non-Radiographic Axial Spondyloarthritis and Ankylosing Spondylitis and Independent of Gender Influences Background/Purpose: Axial spondyloarthritis (SpA) covers both ankylosing spondylitis (AS)…Abstract Number: 2474 • 2013 ACR/ARHP Annual Meeting
Fat Mass and Resistin: Predictive Factors For Anti-TNF Therapy Response In Ankylosing Spondylitis Patients
Background/Purpose: The adipose tissue immune properties and pharmacokinetic consequences can contribute to the pathogenesis of inflammatory conditions. The hole of fat tissue in active Ankylosing…Abstract Number: 2475 • 2013 ACR/ARHP Annual Meeting
Relationship Between Extra-Articular Manifestations and Disease Activity In Patients Diagnosed With New-Onset Spondyloarthropathy In a Cohort In Spain
Background/Purpose : The Spondyloarthropathy (SpA) that affect in many aspects of life of the patients, either for their musculoskeletal or extra-articular manifestations (EAM). EAM vary…Abstract Number: 2476 • 2013 ACR/ARHP Annual Meeting
Periodontal Disease Is Not Associated With Ankylosing Spondylitis and TNF-Alpha Blockers Usage In Korea
Background/Purpose: Periodontal disease (PD) is a chronic inflammatory disease, which has been reported to be associated with rheumatoid arthritis (RA). But, a few studies on…Abstract Number: 2477 • 2013 ACR/ARHP Annual Meeting
Impact Of Stressful Life Events On Disease Activity In Spondyloarthritis: Results Of The Coenv-2 Prospective Cohort Study
Background/Purpose: The relative contribution of environmental factors to triggering and/or progression of spondyloarthritis (SpA) remains poorly characterized. A link between disease activity and stressful life…
ACR Meeting Abstracts